Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Estrogen-progestin replacement and risk of breast cancer

Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R.

JAMA. 2000 Aug 9;284(6):691-4. No abstract available.

PMID:
10927819
2.

Estrogen-progestin replacement therapy and breast cancer risk: the Women's Health Study (United States).

Porch JV, Lee IM, Cook NR, Rexrode KM, Burin JE.

Cancer Causes Control. 2002 Nov;13(9):847-54.

PMID:
12462550
3.

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.

Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R.

JAMA. 2000 Jan 26;283(4):485-91. Erratum in: JAMA 2000 Nov 22-29;284(20):2597.

PMID:
10659874
4.

Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.

Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA.

JAMA. 1995 Jul 12;274(2):137-42.

PMID:
7596001
5.

Breast cancer risk with postmenopausal hormonal treatment.

Collins JA, Blake JM, Crosignani PG.

Hum Reprod Update. 2005 Nov-Dec;11(6):545-60. Epub 2005 Sep 8. Review. Erratum in: Hum Reprod Update. 2006 May-Jun;12(3):331.

PMID:
16150813
6.

Postmenopausal estrogen and progestin use in relation to breast cancer risk.

Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, Willett WC, Stampfer MJ.

Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):593-600.

7.

Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.

Pike MC, Ross RK.

Steroids. 2000 Oct-Nov;65(10-11):659-64.

PMID:
11108873
8.

Menopausal hormone replacement therapy and risk of ovarian cancer.

Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C.

JAMA. 2002 Jul 17;288(3):334-41. Erratum in: JAMA 2002 Nov 27;288(20):2544.

PMID:
12117398
9.

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.

Ross RK, Paganini-Hill A, Wan PC, Pike MC.

J Natl Cancer Inst. 2000 Feb 16;92(4):328-32.

PMID:
10675382
10.

Estrogen-progestin replacement therapy and endometrial cancer.

Pike MC, Peters RK, Cozen W, Probst-Hensch NM, Felix JC, Wan PC, Mack TM.

J Natl Cancer Inst. 1997 Aug 6;89(15):1110-6.

PMID:
9262248
11.

Exogenous progestins and breast cancer.

Stanford JL, Thomas DB.

Epidemiol Rev. 1993;15(1):98-107. Review.

PMID:
8405216
12.

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A; WHI Investigators.

JAMA. 2003 Jun 25;289(24):3243-53.

PMID:
12824205
13.

Estrogen, estrogen plus progestin therapy, and risk of breast cancer.

Colditz GA.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 2):909s-17s. Review.

14.

Postmenopausal estrogen-containing hormone therapy and the risk of breast cancer.

Jick SS, Hagberg KW, Kaye JA, Jick H.

Obstet Gynecol. 2009 Jan;113(1):74-80. doi: 10.1097/AOG.0b013e31818fdde4.

PMID:
19104362
15.
16.

Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.

van Leeuwen FE.

Acta Endocrinol (Copenh). 1991;125 Suppl 1:13-26. Review.

PMID:
1801500
17.

[Revised postmenopausal treatments? A new polemic!].

Foidart JM, Desreux J, Pintiaux A.

Rev Med Liege. 2000 Mar;55(3):156-60. French.

PMID:
10823005
18.

Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.

Nozaki M, Koera K, Nagata H, Nakano H.

J Obstet Gynaecol Res. 2004 Aug;30(4):297-302.

PMID:
15238106
19.

Progestin and breast cancer. The missing pieces of a puzzle.

Giersig C.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Jul;51(7):782-6. doi: 10.1007/s00103-008-0586-6. Review. Erratum in: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Aug;51(8):946.

PMID:
18592338

Supplemental Content

Support Center